Delveinsight

FEBRUARY 9, 2021

Breyanzi will come with a price tag of USD 410,300 wholesale price, said the company, justifying it after taking into consideration several factors including medical and clinical value, patient value, and societal value. Rukobia is the first-in-class HIV attachment inhibitor.

FDA Approval 52

FDA Approval Marketing Research Protein 52

The Pharma Data

OCTOBER 21, 2020

Those drugs belong to a class called tyrosine kinase inhibitors (TKIs), and include Gleevec — the first TKI approved, back in 2001 — as well as newer ones like Sprycel and Bosulif. When it came to market in 2014, the price tag for one treatment cycle was $89,000. The chemo-free approach could shorten that.

Drugs 52

Drugs Genetics Trials Research 52

The Pharma Data

OCTOBER 21, 2020

Those drugs belong to a class called tyrosine kinase inhibitors (TKIs), and include Gleevec — the first TKI approved, back in 2001 — as well as newer ones like Sprycel and Bosulif. When it came to market in 2014, the price tag for one treatment cycle was $89,000. The chemo-free approach could shorten that.

Drugs 52

Drugs Genetics Trials Research 52

The Pharma Data

MAY 4, 2021

and developed Europe following the approvals in 2019 for combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced renal cell carcinoma; as well as. It is the first orally administered coronavirus-specific investigational protease inhibitor to be evaluated in clinical studies.

Vaccination 40

Vaccination Vaccine Production Sales 40